Epigenomic profiling enables unique insights into human development and diseases. Often the analysis of bulk samples remains the only feasible option for studying complex tissues and organs in large patient cohorts, masking the signatures of important cell populations in convoluted signals. DNA methylomes are highly cell type-specific, enabling recovery of hidden components using advanced computational methods without the need of reference profiles. We propose a three-stage protocol for reference-free deconvolution of DNA methylomes comprising: (i) data preprocessing, confounder adjustment and feature selection, (ii) deconvolution with multiple parameters, and (iii) guided biological inference and validation of deconvolution results. Our protocol simplifies the analysis and integration of DNA methylomes derived from complex tissues, including tumors. Applying this protocol to lung cancer methylomes from TCGA revealed components linked to stromal cells, tumor-infiltrating immune cells, and associations with clinical parameters. The protocol takes less than four days to complete and requires basic R skills.
Introduction
DNA methylation, preferentially occurring at CpG dinucleotides in mammalian genomes, correlates with cell type identity and differentiation stage 1 . Importantly, methylation states of particular CpGs can be used as powerful biomarkers for various conditions, including cancer [2] [3] [4] , inflammatory diseases 5 and aging 6 . To facilitate such findings, large international consortia, including IHEC 7 , DEEP 1 , and BLUEPRINT 8 , are generating genome-wide DNA methylation maps (or DNA methylomes) of primary tissue samples and isolated cell populations. However, DNA methylomes obtained from bulk samples are intrinsically heterogeneous, and can be additionally affected by aging, sex and other confounders. Computational methods for the integration of large-scale DNA methylation datasets, and capable of delineating such complex methylomes into biologically distinct variability components, are of paramount importance 9 .
Deconvolution methods dissect methylomes of cell mixtures into their basic constituents 10 . In case reference DNA methylomes of purified cell types are available, these can be used to infer the proportions of different cell types across the samples. Multiple reference-based methods have been proposed [11] [12] [13] and are reviewed elsewhere 14 (summarized in Supplementary Table 1 ). Another class of methods allows for composition-adjusted identification of differentially methylated regions in epigenome-wide association studies (EWAS) without explicitly computing the cell type proportions 15, 16 . When reference methylomes and other prior information is partially or completely absent, semi-reference-free (BayesCCE 17 ) or fully reference-free (RefFreeCellMix 18 , EDec 19 , MeDeCom 20 ) deconvolution methods can be applied ( Supplementary Table 1 ). Reference-free methods are of particular benefit for poorly characterized, complex systems, where adequate reference profiles are especially hard to obtain. These tissues include for instance brain, and solid tumors. We earlier found that in a large variety of applications, reference-free deconvolution methods are only marginally different in their accuracy, and a thorough preprocessing, as well as careful feature selection are more important than the choice of the deconvolution tool 21 . Furthermore, interpretation of deconvolution results is challenging in case prior information about the investigated biological system is limited. Here, we present a comprehensive pipeline that facilitates reference-free deconvolution, starting from raw DNA methylation data down to result interpretation. Although we focus on MeDeCom as a representative method, the protocol is not limited to a single deconvolution method and can be used in combination with other available tools.
Development of the protocol
Reference-free deconvolution is a challenging computational task, for which several methods have been proposed, along with the tools implementing them ( Supplementary Table 1 ). However, in a pilot benchmark of several published reference-free deconvolution tools, we found that their performance differences were marginal, both on fully synthetic and in silico mixed experimental datasets 21 . In fact, the quality and information content of the input DNA methylation matrix had a higher impact upon the accuracy, than the choice of the deconvolution tool itself. Thus, deconvolution algorithms a priori rely on thorough data processing and feature selection, especially if the differences between underlying components are small. Furthermore, biological interpretation of deconvolution results is often challenging, in particular for beginners with limited bioinformatic experience. Facilitating the generation of biological insights about the investigated system is similarly important as the deconvolution itself. To overcome these limitations, we developed a comprehensive, three-stage protocol, which includes critical preprocessing and interpretation steps in addition to the actual deconvolution. The protocol, schematically outlined in Fig. 1 , consists of three main stages: (i) state-of-the-art DNA methylation data preparation, including stringent, quality-adapted CpG filtering, elimination of potential confounding factors using Independent Component Analysis (ICA) and feature selection; (ii) reference-free methylome deconvolution; (iii) interpretation of deconvolution results with a user-friendly R/Shiny-based interface, enabling generating novel biological insights.
As earlier described, data preparation is key to the overall success of deconvolution. The first stage of our protocol thus comprises quality-adapted removal of unreliable or otherwise problematic measurements using the widely used RnBeads software package for data handling 22, 23 . Confounding factors, such as age, sex or donor genotype, can have a strong influence on the methylome, and investigators might want to adjust for those in their analyses 24, 25 . Therefore, we argue that accounting for confounders, using methods such as Independent Component Analysis (ICA) 26 , is crucial to obtain biologically relevant results. As the final data preparation step, a CpG subset selection determines sites that are linked to, for instance, cell type identity or any other phenotypic trait of interest.
The prepared, high-quality data matrix can be subjected to one of the deconvolution tools ( Supplementary Table 1 ). As a rule, these methods decompose input DNA methylation matrix into a matrix of latent methylation components (LMCs, T) and a matrix of proportions (A). In the second stage of the protocol, we use MeDeCom 20 , our own method based on regularized non-negative matrix factorization (NMF). To enforce the bimodality of LMCs, it regularizes the entries of T towards extreme values zero and one. A MeDeCom solution is defined by two user-specified parameters: the number of LMCs K (the inner dimension of T and A), and the quadratic regularization parameter λ (zero for no, and larger than one for strong regularization). Although, the generated cross validation error provides a rational criterion for parameter selection, it is often useful to consider several alternative solutions. MeDeCom therefore stores all results obtained on a reasonable parameter grid for subsequent in-depth exploration.
Although reference-free deconvolution is flexible with respect to the investigated system, the interpretation of deconvolution results, especially of the LMC matrix T, can be challenging. In addition to cell type profiles, LMCs reflect multiple drivers of biological and technical variability, including age or sex. Furthermore, validating the proportions and LMCs is not trivial, since the space of possible solutions is large and the cellular composition is typically unknown. In order to guide users, we implemented most of the interpretation functionality in the form of a specialized R/Shiny-based graphical user interface (FactorViz). A detailed description of the annotation and inference features implemented in FactorViz is given in the Outline of the Procedure section below.
Applications of the methods
Reference-free deconvolution is the method of choice for studying heterogeneity of DNA methylomes in biological systems with limited prior knowledge about their cellular composition, or in case of missing reference profiles. This includes EWAS using material from hardly-accessible or insufficiently-characterized organs and tissues, such as human brain, as well as solid tumors. Previously, we and others used this approach to understand cellular heterogeneity in placenta 27 , multiple sclerosis 28 , breast cancer 19 , and cholangiocarcinoma 29 . Reference-free deconvolution is particularly useful to dissect tumor heterogeneity, e.g. to study the effect of tumor-infiltrating immune cells on the tumor microenvironment 30 . Furthermore, identified LMCs can be correlated to tumor size, location, metastasis state, and mutational burden. Since tumors in general show a high degree of sample-to-sample variation, methylome deconvolution can be used to detect similarities among different types of cancers to define pan-cancer and cancer type-specific markers. If a particular cancer induces changes in the DNA methylation pattern of the tumor stroma, these changes are likely to be missed by reference-based, but not by reference-free methods.
In the original publication, after the validation on simulated data and in-silico cell type mixtures, MeDeCom was applied to a brain frontal cortex dataset, successfully separating it into neuronal and glia fractions, as well as detecting additional LMCs, which could be linked to features of Alzheimer's disease 20 . We anticipate successful application of MeDeCom in similar scenarios. Furthermore, although for blood-based studies reference methylomes exist and reference-based methods perform generally well, reference-free deconvolution can be useful in case of severely altered blood composition, e.g. due to an overproduction of rare cell types.
Finally, in the case of blood and other similarly well characterized tissues, MeDeCom can be applied in a semi-supervised fashion using spiked-in reference profiles. This enables easy recovery of known signatures, and allows for detection of additional unknown LMCs.
Single-cell technology is steadily improving, and cell-level DNA methylomes will become increasingly available in the near future 31, 32 . Nevertheless, we expect that deconvolution of large-scale bulk tissue datasets will remain a useful complement of single cell DNA methylation profiling, which still suffers from high costs, low sample throughput and data sparsity. We envisage that both approaches can be successfully used in combination, e.g. single-cell profiling in several reference samples followed by deconvolution of bulk methylomes from large patient cohorts, where single-cell profiles can be used for interpretation of the LMCs or as pivot profiles in semi-reference-free scenarios. Finally, deconvolution of more accessible bulk methylomes can be used to integrate them with easier to obtain single-cell profiles of other omics layers, including single-cell transcriptomes and chromatin accessibility maps.
Outline of the procedure
Our protocol is divided into three main stages: (i) Data preparation, (ii) Deconvolution and (iii) Interpretation, which are described in detail below (see also Fig. 1 ).
Data preparation
We implemented the data preparation stage of the protocol as a new R-package (DecompPipeline) that integrates quality filtering, confounding factor adjustment and feature selection steps into an easy-to-use workflow (http://github.com/CompEpigen/DecompPipeline). For loading, formatting and storing DNA methylation data we recommend our recently updated RnBeads package.
Data import. Genome-wide DNA methylation can be profiled by different technologies such as whole-genome bisulfite sequencing (WGBS), reduced-representation bisulfite sequencing (RRBS) or the Illumina Infinium microarrays. In this protocol we focus on microarray datasets due to their larger sample sizes that increase the efficiency of deconvolution. Nevertheless, our pipeline is similarly applicable to any other data type that provides DNA methylation calls at single CpG resolution, given at least a dozen samples are available. In addition to raw DNA methylation data, phenotypic information is required and converted into the internal RnBeads 22,23 data structure. The input is checked for data quality using RnBeads' reporting functionality.
Quality filtering. DecompPipeline performs quality-based filtering of CpGs across the samples in several steps ( Table 1) . First, CpGs are filtered according to a coverage threshold across the samples, and overall signal intensity (microarrays) or coverage (bisulfite sequencing) outliers are removed. Missing values can either be completely discarded from the dataset or imputed 33 . We further remove sites overlapping annotated or estimated single nucleotide polymorphisms (SNPs), sites on the sex chromosomes and cross-reactive sites 34 . Infinium data should be normalized prior to downstream analysis, and further sample properties can be inferred, such as the overall immune cell content using the LUMP algorithm 35 or the epigenetic age 25 .
Covariate adjustment using ICA. DNA methylomes can be affected by various sources of variability, both of biological and technical nature that might mask the signals of interest. Independent component analysis (ICA) 26 is a data-driven dimensionality reduction method that performs a matrix decomposition, dividing the experimentally observed data matrix D mn into k independent signals S mk mixed with the coefficients of M kn :
where m and n are the number of features (methylation sites) and samples, respectively. S represents the contributions of methylation sites in different components. The weight matrix M can be linked to clinical outcomes, such as cancer type and patient survival, and confounding factors, including sex, experimental batch effects or platform biases. As the method separates the original methylation profiles into statistically independent signals, the influence of potential confounding factors on the methylation profiles can be attributed to particular CpGs, which can either be removed or the weights (rows of M) of corresponding components can be set to zero 36 .
A pitfall of ICA that is specific to methylation data analysis is the smoothing of the original beta value distribution after ICA-based normalization. Therefore, a post-processing step is required in order to bring beta values into the expected range. To achieve this, reconstructed values are linearly rescaled in order to set the 1 st and 99 th percentiles to beta values of zero and one. Finally, in order to reduce stochasticity of ICA decomposition, we apply the consensus ICA approach 37 . ICA was run multiple times and the resulting matrices S and M were mapped and averaged between the runs. The stability of the components is estimated as the coefficient of determination (R 2 ) between the columns of S observed in different runs.
Selection of informative CpG subsets.
In order to obtain satisfactory deconvolution results, further feature selection is required, since, for instance, lowly variable CpGs do not contribute to signature recovery, but add to the computational runtime. From our experience, using prior knowledge about the underlying cell types is the best option, given such knowledge is available 11, 19 . In the absence of prior knowledge about the biological system of interest, typical strategies for feature selection include selecting the most variable sites, the ones with the highest loadings on the first few principal components, or a random selection. DecompPipeline provides 14 options to select CpG subsets ( Table 2 [38] [39] [40] ), and multiple of these options can be included in a single execution of the pipeline.
Performing deconvolution using MeDeCom
Reference-free deconvolution methods, such as RefFreeCellMix 18 , EDec 19 or MeDeCom 20 , estimate the matrix of latent methylation components (T) and the matrix of proportions (A) based on the DNA methylation matrix of sites selected in the previous step (D) by means of non-negative matrix factorization. We focus on MeDeCom, but the pipeline similarly supports RefFreeCellMix and EDec. MeDeCom optimizes the squared Frobenius norm of the difference between the true (measured) methylation matrix D and the matrix product of T and A (Fig. 1) . Desired properties of the factor matrices, i.e. restriction to the [0, 1] interval (T and A) and column-sums equal to one (A), are enforced by respective constraints on their entries. Furthermore, MeDeCom penalizes the entries of T not equal to zero and one using quadratic regularization (maximum at entries equal to 0.5) controlled by the regularization parameter λ .
The optimization problem is solved using an alternating optimization scheme, which fixes either of A or T while fitting the other at each of its steps. Selecting suitable values for the regularization parameter (λ) and the number of latent components (K) is assisted by a crossvalidation scheme that leaves out columns of D. Typically, a grid search for different values of K and λ is performed to determine the best number of components and regularization, respectively. In order to reduce running time substantially, we recommend activating the parallel processing options on standalone workstations, or to use a high-performance computing cluster. The resulting solutions of the deconvolution problem are stored on disk and can be used for downstream interpretation.
Interpretation of deconvolution results
In contrast to reference-based deconvolution, interpretation of reference-free deconvolution results is non-trivial. MeDeCom produces a matrix of LMCs and a matched proportion matrix, both of which need to be biologically validated and interpreted. To facilitate an interactive interpretation, we created the semi-automated visualization tool FactorViz (https://github.com/CompEpigen/FactorViz). FactorViz is an R/Shiny-based user interface with guidelines and functions for comprehensive biological inference. Initially, one of the possible MeDeCom solutions has to be chosen by selecting the parameters K and λ based on the cross-validation error. In order to investigate potential influences of covariates upon the estimated proportions and corresponding LMCs, the resulting proportion matrix is linked to technical or phenotypic traits, such as experimental batch or subject age, using association tests. Furthermore, proportions can be linked to marker gene expression values, or specific properties of the analyzed dataset such as survival time. To functionally annotate LMCs, we determine the sites that are specifically hypomethylated in a particular LMC in comparison to the median of the remaining LMCs, and treat the obtained sites as LMC-specific. Those sites are then used for GO 41 and LOLA 42 enrichment analysis in order to associate respective LMCs with functional categories, pathways and various genomic features. Finally, the matrix of LMCs can be compared with available reference cell type profiles.
Level of expertise needed to implement the method
DecompPipeline, MeDeCom, and FactorViz are R-packages and thus require some minimal prior experience with the R programming language. Basic knowledge of the Unix command line interface is recommended for data handling. To follow the steps of this protocol, one only needs a few R function calls, but the function parameters need to be tailored to the target dataset. The graphical user interface FactorViz presents plots, which require a minimum knowledge of DNA methylation data and matrix factorization.
Limitations
Since MeDeCom tests all possible combinations of the regularization parameter λ , the number of LMCs K and several feature selection methods, the number of basic deconvolution jobs can reach 1,000 -10,000. Reference-free deconvolution is thus a computationally demanding task that requires high-performance computing infrastructure. When applied to larger datasets, the deconvolution can take several days to finish even on larger machines. Furthermore, the obtained LMC matrix needs to be biologically interpreted, which requires user interaction and input. A fully-automated interpretation of deconvolution results will be part of the next development steps of the protocol. Accounting for confounding factors, especially for those that might have a strong influence on the methylome, can lead to a substantially modified DNA methylation data matrix. The proposed pipeline provides diagnostic plots, but user interaction is still required to determine if the effect of a particular covariate is to be removed.
Materials

Hardware
We recommend to apply the proposed protocol on large systems with, e.g. 128 GB of main memory and 32 cores for a dataset of this size. For larger datasets such as bisulfite sequencing data, we recommend a transition to a high-performance compute cluster or a cloud environment, such that the pipeline can automatically distribute jobs across different machines. MeDeCom, FactorViz and DecompPipeline can be directly installed from GitHub on Unix-like systems, and a Docker container is available also for Windows 10 systems (https://hub.docker.com/r/mscherer/medecom).
Input data
We used publicly available data from The Cancer Genome Atlas (TCGA, https://www.cancer.gov/tcga) investigating lung adenocarcinoma (dataset TCGA-LUAD, https://portal.gdc.cancer.gov/legacy-archive/search/f) in 461 samples assayed using the Illumina 450k microarray, since lung cancer has high cellular and molecular heterogeneity 43 . The clinical metadata and the manifest file of the samples is available at https://portal.gdc.cancer.gov/projects/TCGA-LUAD and have been downloaded through the TCGA legacy archive on 2019-01-23. We used the Genomic Data Commons (GDC) data download tool (https://gdc.cancer.gov/access-data/gdc-data-transfer-tool) together with the manifest file to download the intensity data (IDAT) files and associated metadata.
Procedure
Installation TIMING 1 h 1. The pipeline needs R installed on your machine. If it is not yet installed, follow the instructions at https://cran.r-project.org/.
2. Invoke R on the command line and install the devtools package. Then, install the software packages needed for deconvolution directly from GitHub: MeDeCom, DecompPipeline and FactorViz, and RnBeads from Bioconductor.
install.packages(c("devtools","BiocManager")) BiocManager::install("RnBeads") library(devtools) devtools::install_github( c("lutsik/MeDeCom","CompEpigen/DecompPipeline","CompEpigen/FactorViz") ) library(DecompPipeline)
Data retrieval TIMING 5 h
3.
Use the Genomic Data Commons (GDC) data download tool (https://gdc.cancer.gov/access-data/gdc-data-transfer-tool) to download the IDAT files listed in the manifest file and its associated metadata. This metadata also includes the mapping between each of the samples and the IDAT files.
gdc-client download -m gdc_manifest.2019-07-03.txt clinical.data <-read.table("annotation/clinical.tsv", sep ="\ t", header = TRUE ) idat.files <-list.files("idat",full.names = TRUE) meta.files<-list.files(idat.files [1] ,full.names = TRUE) untar(meta.files [3] ,exdir = idat.files [1] ) meta.files <-untar(meta.files [3] ,list = TRUE) meta.info <-read. 6 . Specify the input to RnBeads: the sample annotation sheet created at the data retrieval step, the folder in which the IDAT files are stored and a folder to which the HTML report is to be saved. Additionally, specify a temporary directory and start the RnBeads analysis. sample.anno <-"annotation/sample_annotation.tsv" idat.folder <-"idat/" dir.report <-paste0("report",Sys.Date(),"/") temp.dir <-"/tmp" options(fftempdir = temp.dir) rnb.set <-rnb.run.analysis( dir.reports = dir.report, sample.sheet = sample.anno, data.dir = idat.folder ) 7 . RnBeads creates an interactive HTML report, specifying the steps performed and the associated results. Data should meet the quality criteria in Table 3 to be used for downstream analysis (see also the Anticipated Results section).
Preprocessing and filtering TIMING 22 h
8. Use the DecompPipeline package (https://github.com/CompEpigen/DecompPipeline) for further analysis. Processing options are provided through individual function parameters. Follow a stringent filtering strategy: (i) Filter CpGs covered by less than 3 beads, and probes that are in the 0.001 and 0.999 overall intensity quantiles (low and high intensity outliers). (ii) Remove all probes containing missing values in any of the samples. (iii) In the sequence context filtering, sites outside of CpG context, overlapping annotated SNPs, located on the sex chromosomes and potentially cross-reactive probes are discarded. Finally, upon successful filtering, apply BMIQ normalization 44 to account for the bias introduced by the two Infinium probe designs 45 .
CRITICAL STEP Removing too few or too many sites might have a strong influence on the final deconvolution results. Thus, we recommend to carefully check the available options ( Table 1 ) and only change the default setting in case of low-quality data. 9. Accounting for potential confounding factors is crucial in epigenomic studies and the influences of, for instance, donor sex, age, and genotype on the DNA methylation pattern are well-studied 24, 25 . Use Independent Component Analysis (ICA, see Materials) to account for DNA methylation differences that are due to sex, age, race, and ethnicity. 
CRITICAL STEP
Downstream analysis TIMING 1 h
12. Visualize and interactively explore the deconvolution results with FactorViz (Supplementary Fig. 1 ). library(FactorViz) startFactorViz(file.path(getwd(),"TCGA_LUAD","FactorViz_outputs")) 13 . Determine the number of components and the regularization parameter from the provided list of parameters ( Supplementary Fig. 2 ).
14.
Associate the proportion matrix with quantitative (mutation count, fraction of genome altered, LUMP estimate, stromal score) and qualitative (sex, ethnicity, health state, copy number states) traits using correlation-and t-tests, respectively (Supplementary Fig. 3 ).
CRITICAL STEP Interpretation of deconvolution results is crucial to obtain biological insights about the investigated system. In addition to the interpretation functions provided by FactorViz, prior knowledge about the system can be used to validate and interpret deconvolution results. 15 . Compare LMC proportions per sample to expression of epithelial, endothelial, stromal, and immune cell marker genes in lung tissue 46 (Supplementary Text) . 16 . To determine sites that are specifically hypo-and hypermethylated in an LMC, compare the methylation values in the LMC matrix for each LMC to the median of the remaining LMCs and then employ GO and LOLA enrichment analysis (Supplementary Fig. 4) .
We provide troubleshooting advice in Table 4 . For further support questions, feature requests or help, use GitHub's issue system or write a mail to the tool developers.
Anticipated Results
Quality control and feature selection
Deconvolution analysis requires input DNA methylation data of good technical quality, which we verified using RnBeads' QC module. In the example analysis, quality control probes on the Infinium array did not reveal low-quality samples to be removed. Verifiable phenotypic information matched the inferred sample properties, such as predicted sex of all subjects (Fig.  2) . We used several criteria to select a set of high-confidence CpGs as input to MeDeCom. Most of the discarded sites (39.5%) were removed, because they were covered by less than three beads in any of the samples, or showed unusually high or low intensity. Further CpG filtering steps, including sequence context (SNPs, sites on the sex chromosomes, 10.5%) and removal of cross-reactive probes 34 (2.5%) eliminated further problematic sites. As a final outcome of the filtering procedure, 230,223 sites (47.4% of 485,577) passed our stringent quality criteria and were used for downstream analysis (Fig. 2) .
Confounding factor analysis
To evaluate ICA, we applied the proposed workflow to the TCGA dataset twice: once without correcting for age, sex, race, and ethnicity, and once with the adjustment using ICA (Fig. 3A) . ICA detected 22 components, of which two were significantly associated with sex and ethnicity, respectively (Fig. 3B) . The overall distribution of the DNA methylation matrix was still bimodal after ICA adjustment, although there were notable peaks at methylation values zero and one, respectively. We argue that these peaks are a consequence of the linear scaling ( Fig. 3C) . After employing MeDeCom independently on the modified and the unadjusted DNA methylation matrix, three of the detected components were significantly linked to sex in the unadjusted (p-values: LMC1: 6x10 -4 , LMC4: 1.4x10 -5 , LMC5: 3x10 -3 ), but only one component was mildly linked to sex in the adjusted run (LMC7, p-value: 7.8x10 -4 , Fig. 3D ). Although ICA component 11 was linked to ethnicity, we could not find a similar association with LMCs. Notably, neither age nor race variables were significantly linked to any component produced by either ICA or MeDeCom.
Deconvolution results
The results of applying the proposed protocol to the TCGA LUAD dataset are shown in Fig. 4 . Since we did not have prior knowledge on the expected number of underlying cell types to select, we resorted to the cross-validation procedure of MeDeCom. We chose 7 LMCs as the value of K at which the cross-validation error started to level out (Supplementary Fig. 5A) . Similarly, we selected λ =0.001 as the regularization parameter (Supplementary Fig. 5B) . Notably, LMC5 was particularly hypomethylated and LMC6 showed a high overall methylation level, while the remaining LMCs were rather intermediately methylated (Supplementary Fig.  5C, D) .
We further investigated the biological implications of the detected LMCs. To this end, we found that LMC5 had substantially higher proportions in the healthy tissue samples (Fig. 4A) . This indicated that reference-free deconvolution was able to capture the inherent methylation signatures specific to cancerous and healthy tissues. When we conducted enrichment analysis for the sites that were particularly hypomethylated in LMC5, we found that transcription factor binding sites for the Polycomb repressive complex (SUZ12, EZH2) were overrepresented. Cancers have a strong influence on the Polycomb repressive complex, which typically represses oncogenes; a process that becomes distorted when its binding sites are hypermethylated [47] [48] [49] . What is more, proportion of LMC5 in tumor tissues provided a generic estimate of tumor sample purity, i.e. degree of contamination by adjacent normal tissue. Thus, we were able to capture tumor-specific methylation signatures without conducting differential analysis between two phenotypic groups.
Next, LMC3 showed highly variable proportions across the samples and was the main driver of the overall sample clustering. LMC3 proportions were strongly correlated with the LUMP estimate ( Fig. 4B) , which predicts the overall immune cell content of a sample 35 . Furthermore, we detected enrichments of LMC3-speficic hypomethylated sites towards leukocyte (Blymphocyte) specific transcription factor binding sites and immune response related GO terms ( Fig. 4C, D, Supplementary Fig. 6 ). We concluded that LMC3 most likely represented tumor infiltrating immune cells. The extent of tumor infiltration might be relevant to associate cancer state to patient prognosis 50 .
To determine whether the detected LMCs reflected the expression of known marker genes of lung tissue cell types, we selected EPCAM as an epithelial, CLDN5 as an endothelial, COL1A2 as a stromal, and PTPRC as an immune cell marker 46 . We collected gene expression data from TCGA for the samples (data processing is described in the Supplementary Text) and found LMC3 to be correlated to PTPRC expression. Furthermore, LMC1 was strongly associated with the epithelial marker expression and LMC5 with the endothelial marker CLDN5 (Fig. 4E) .
Many of the detected components were linked to cancer mutational status, such as overall mutation count or chromosomal gain or loss (Supplementary Fig. 7) , or cancer stemness (Supplementary Fig. 8 ). For instance, LMC1 was inversely linked to copy number gain of chromosome 1p and 16p. We further investigated the sites that were particularly hypo-or hypermethylated in LMC4, since LMC4 showed a high proportion in a small subset of samples that clustered separately from the remaining cancer samples (Fig. 4A) . One of these sites, cg26992600, is located 3 kb upstream of the TSS of NKX2-8, a gene that has potential roles in the progression of lung cancers 51 (Supplementary Fig. 9, Supplementary Table 2) . Finally, in a survival analysis of LMC proportions, we found that proportions of LMC5 and LMC6 were associated with survival time (p-values: LMC5: 0.18, LMC6: 0.03, Supplementary Fig. 10) , warranting further investigation of their biological nature, which, however, exceeded the scope of our example analysis.
Conclusions
Taken together, our methylome deconvolution protocol was able to provide novel biological insights about the cellular and intra-tumor heterogeneity of lung cancer. We expect the protocol to be of great benefit to all investigators performing DNA methylation analysis in complex and underexplored experimental systems, including bulk samples of highly heterogeneous tissues and tumors.
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